Drug Search Results
More Filters [+]

Squalene

Alternative Names: squalene
Latest Update: 2024-08-30
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intramuscular,Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | India | Malaysia | Philippines | Taiwan | United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Monash University Malaysia
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Squalene

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Skin Cancer|Tuberculosis, Cutaneous|Lung Diseases, Fungal|Malaria|Diphtheria|Tuberculosis, Oral|Immune Complex Diseases|Skin Diseases, Bacterial|HIV Infections|Salmonella Infections, Animal|Skin Diseases, Genetic|Influenza, Human|Lung Cancer|Inflammation|Skin Diseases, Infectious|Gram-Negative Bacterial Infections|Measles

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12624001057572

N/A

Not yet recruiting

Unknown

2025-06-30

21HH6540

N/A

Completed

Healthy Volunteers

2022-07-20

BYI-0736

P1

Completed

Salmonella Infections, Animal|Skin Diseases, Bacterial|Influenza, Human|HIV Infections|Skin Cancer|Inflammation|Tuberculosis, Cutaneous|Gram-Negative Bacterial Infections|Measles|Lung Cancer|Lung Diseases, Fungal|Diphtheria|Malaria|Skin Diseases, Infectious|Skin Diseases, Genetic|Immune Complex Diseases|Tuberculosis, Oral

2013-03-01

Recent News Events